BTAX
BIOSTAX CORP by Biostax Corp. (BTAX)
$00
About BIOSTAX CORP by Biostax Corp. (BTAX)
Biostax Corp. engages in the acquisition, development, and commercialization of pharmaceutical and biotechnology products. Its partnered programs include JKB-122, Londonal, and Low Dose Naltrexone. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.15
52 Week Low
$0.00
Market cap
15,700
Dividend yield
0.00%
Volume
--
Avg. volume
460
P/E ratio
-.01
BIOSTAX CORP by Biostax Corp. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.15
52 Week Low
$0.00
Market cap
15,700
Dividend yield
0.00%
Volume
--
Avg. volume
460
P/E ratio
-.01